Soy isoflavones are phytoestrogens with potential hormonal activity due to their similar chemical structure to 17-β-estradiol. The increasing availability of soy isoflavones throughout the food supply and through use of supplements has prompted extensive research on biological benefits to humans in chronic disease prevention and health maintenance. While much of this research has focused on adult populations, infants fed soy protein based infant formulas are exposed to substantial levels of soy isoflavones, even when compared to adult populations that consume a higher quantity of soy-based foods. Infant exposure, through soy formula, primarily occurs from birth to one year of life, a stage of development that is particularly sensitive to dietary and environmental compounds. This has led investigators to study the potential hormonal effects of soy isoflavones on later reproductive health outcomes. Such studies have included minimal human data with the large majority of studies using animal models. This review discusses key aspects of the current human and animal studies and identifies critical areas to be investigated as there is no clear consensus in this research field.
References
[1]
Merritt, R.J.; Jenks, B.H. Safety of soy-based infant formulas containing isoflavones: The clinical evidence. J. Nutr.？2004, 134 (5), 1220–1224. 15113975
[2]
Henley, E.C.; Kuster, J.M. Protein quality evaluation by protein digestibility-corrected amino acid scoring. Food Technol.？1994, 48, 74–77.
[3]
Newberry, R.E. The Infant Formula Act of 1980. J. Assoc. Off. Anal. Chem.？1982, 65 (6), 1472–1473. 7174587
[4]
Centre for Disease Control and Prevention. Breastfeeding Among U.S. Children Born 1999–2007, CDC National Immunization Survey. 2010. Available online: http://www.cdc.gov/breastfeeding/data/NIS_data/ (accessed on 5 April 2010).
[5]
Canadian Paediatric Society, Dietitians of Canada and Health Canada. Statement of joint working group: Nutrition for healthy term infants. 1998. Available online: http://www.hc-sc.gc.ca/fn-an/pubs/infant-nourrisson/nut_infant_nourrisson_term-eng.php (accessed on 5 April 2010).
[6]
American Academy of Pediatrics Committee on Nutrition. Soy protein-based formulas: Recommendations for use in infant feeding. Pediatrics？1998, 101, 148–153, doi:10.1542/peds.101.1.148. 11345979
[7]
UK Department of Health. Advice on Soya-Based Infant Formula; Press Release No. 96/244; Committee on the Toxicity of Chemicals in Food, Consumer Products, and the Environment: London, UK, 1996.
[8]
Australian College of Pediatrics. Positition statement: Soy protein formula. J. Paediatr. Child Health？1998, 34, 318–319, doi:10.1046/j.1440-1754.1998.d01-517.x. 9727169
[9]
Setchell, K.D.; Zimmer-Nechemias, L.; Cai, J.; Heubi, J.E. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am. J. Clin. Nutr.？1998, 68 (6), 1453–1461. 9848516
[10]
Leclercq, G.; Heuson, J.C. Physiological and pharmacological effects of estrogens in breast cancer. Biochim. Biophys. Acta？1979, 560 (4), 427–455. 391285
[11]
Setchell, K.D. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr.？1998, 68 (6), 1333–1346. 9848496
Zhang, E.J.; Ng, K.M.; Luo, K.Q. Extraction and purification of isoflavones from soybeans and characterization of their estrogenic activities. J. Agric. Food. Chem.？2007, 55 (17), 6940–6950. 17658826
[14]
Setchell, K.D.; Zimmer-Nechemias, L.; Cai, J.; Heubi, J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet？1997, 350 (9070), 23–27. 9217716
[15]
Somekawa, Y.; Chiguchi, M.; Ishibashi, T.; Aso, T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet. Gynecol.？2001, 97 (1), 109–115, doi:10.1016/S0029-7844(00)01080-2. 11152918
[16]
Strom, B.L.; Schinnar, R.; Ziegler, E.E.; Barnhart, K.T.; Sammel, M.D.; Macones, G.A.; Stallings, V.A.; Drulis, J.M.; Nelson, S.E.; Hanson, S.A. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA？2001, 286 (7), 807–814. 11497534
[17]
Fontenele, E.G.; Martins, M.R.; Quidute, A.R.; Montenegro R.M., Jr. Environmental contaminants and endocrine disruptors. Arq. Bras. Endocrinol. Metabol.？2010, 54 (1), 6–16. 20414542
[18]
Gu, L.; House, S.E.; Prior, R.L.; Fang, N.; Ronis, M.J.; Clarkson, T.B.; Wilson, M.E.; Badger, T.M. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J. Nutr.？2006, 136 (5), 1215–1221. 16614407
[19]
Jefferson, W.N.; Doerge, D.; Padilla-Banks, E.; Woodling, K.A.; Kissling, G.E.; Newbold, R. Oral exposure to genistin, the glycosylated form of genistein, during neonatal life adversely affects the female reproductive system. Environ. Health Perspect.？2009, 117 (12), 1883–1889. 20049207
[20]
Kaludjerovic, J.; Ward, W.E. Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice. J. Nutr.？2009, 139 (3), 467–473, doi:10.3945/jn.108.100115. 19158220
[21]
Lewis, R.W.; Brooks, N.; Milburn, G.M.; Soames, A.; Stone, S.; Hall, M.; Ashby, J. The effects of the phytoestrogen genistein on the postnatal development of the rat. Toxicol. Sci.？2003, 71 (1), 74–83, doi:10.1093/toxsci/71.1.74. 12520077
Doerge, D.R.; Twaddle, N.C.; Banks, E.P.; Jefferson, W.N.; Newbold, R.R. Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice. Cancer Lett.？2002, 184 (1), 21–27, doi:10.1016/S0304-3835(02)00200-8. 12104044
[24]
Barrett, J.R. Soy and children’s health: A formula for trouble. Environ. Health Perspect.？2002, 110 (6), A294–A296, doi:10.1289/ehp.110-a294. 12055058
[25]
Woods, H.F. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment: Phytoestrogens and Health; Food Standards Agency: London, UK, 2003; COT Report No. FSA/0826/0503, pp. 357–360.
[26]
Updated Evaluation of Soy Infant Formula: Final Expert Panel Report; National Institutes of Health: Bethesda, MD, USA, 2010; Federal Register Report No. 53508.
[27]
Final CERHR Expert Panel Report on Soy Formula; National Institutes of Health: Bethesda, MD, USA, 2006; Federal Register Report No. 65537.
[28]
Jefferson, W.N.; Padilla-Banks, E.; Clark, G.; Newbold, R.R. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. B？2002, 777 (1-2), 179–189, doi:10.1016/S1570-0232(02)00493-2.
[29]
Jefferson, W.N.; Couse, J.F.; Padilla-Banks, E.; Korach, K.S.; Newbold, R.R. Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: Evidence for ERbeta-mediated and nonestrogenic actions. Biol. Reprod.？2002, 67 (4), 1285–1296, doi:10.1095/biolreprod67.4.1285. 12297547
[30]
Padilla-Banks, E.; Jefferson, W.N.; Newbold, R.R. Neonatal exposure to the phytoestrogen genistein alters mammary gland growth and developmental programming of hormone receptor levels. Endocrinology？2006, 147 (10), 4871–4882, doi:10.1210/en.2006-0389. 16857750
[31]
Jefferson, W.N.; Padilla-Banks, E.; Newbold, R.R. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol. Reprod.？2005, 73 (4), 798–806, doi:10.1095/biolreprod.105.041277. 15930323
[32]
Nagao, T.; Yoshimura, S.; Saito, Y.; Nakagomi, M.; Usumi, K.; Ono, H. Reproductive effects in male and female rats of neonatal exposure to genistein. Reprod. Toxicol.？2001, 15 (4), 399–411, doi:10.1016/S0890-6238(01)00141-1. 11489596
[33]
Jefferson, W.; Newbold, R.; Padilla-Banks, E.; Pepling, M. Neonatal genistein treatment alters ovarian differentiation in the mouse: Inhibition of oocyte nest breakdown and increased oocyte survival. Biol. Reprod.？2006, 74 (1), 161–168. 16192398
[34]
Newbold, R.R.; Banks, E.P.; Bullock, B.; Jefferson, W.N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res.？2001, 61 (11), 4325–4328. 11389053
[35]
Jefferson, W.N.; Padilla-Banks, E.; Goulding, E.H.; Lao, S.P.; Newbold, R.R.; Williams, C.J. Neonatal exposure to genistein disrupts ability of female mouse reproductive tract to support preimplantation embryo development and implantation. Biol. Reprod.？2009, 80 (3), 425–431. 19005167
[36]
Kouki, T.; Kishitake, M.; Okamoto, M.; Oosuka, I.; Takebe, M.; Yamanouchi, K. Effects of neonatal treatment with phytoestrogens, genistein and daidzein, on sex difference in female rat brain function: Estrous cycle and lordosis. Horm. Behav.？2003, 44 (2), 140–145, doi:10.1016/S0018-506X(03)00122-3. 13129486
[37]
Lamartiniere, C.A.; Zhang, J.X.; Cotroneo, M.S. Genistein studies in rats: Potential for breast cancer prevention and reproductive and developmental toxicity. Am. J. Clin. Nutr.？1998, 68 (6), 1400–1405. 9848507
[38]
Atanassova, N.; McKinnell, C.; Turner, K.J.; Walker, M.; Fisher, J.S.; Morley, M.; Millar, M.R.; Groome, N.P.; Sharpe, R.M. Comparative effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: Evidence for stimulatory effects of low estrogen levels. Endocrinology？2000, 141 (10), 3898–3907. 11014247
[39]
Sharpe, R.M.; Martin, B.; Morris, K.; Greig, I.; McKinnell, C.; McNeilly, A.S.; Walker, M. Infant feeding with soy formula milk: Effects on the testis and on blood testosterone levels in marmoset monkeys during the period of neonatal testicular activity. Hum. Reprod.？2002, 17 (7), 1692–1703. 12093826
[40]
Tan, K.A.; Walker, M.; Morris, K.; Greig, I.; Mason, J.I.; Sharpe, R.M. Infant feeding with soy formula milk: Effects on puberty progression, reproductive function and testicular cell numbers in marmoset monkeys in adulthood. Hum. Reprod.？2006, 21 (4), 896–904. 16476680
[41]
Bernbaum, J.C.; Umbach, D.M.; Ragan, N.B.; Ballard, J.L.; Archer, J.I.; Schmidt-Davis, H.; Rogan, W.J. Pilot studies of estrogen-related physical findings in infants. Environ. Health Perspect.？2008, 116 (3), 416–420. 18335112
[42]
Zung, A.; Glaser, T.; Kerem, Z.; Zadik, Z. Breast development in the first 2 years of life: An association with soy-based infant formulas. J. Pediatr. Gastroenterol. Nutr.？2008, 46 (2), 191–195, doi:10.1097/MPG.0b013e318159e6ae. 18223379
[43]
Gilchrist, J.M.; Moore, M.B.; Andres, A.; Estroff, J.A.; Badger, T.M. Ultrasonographic patterns of reproductive organs in infants fed soy formula: comparisons to infants fed breast milk and milk formula. J. Pediatr.？2010, 156 (2), 215–220, doi:10.1016/j.jpeds.2009.08.043. 19846109
[44]
Russo, I.H.; Russo, J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J. Natl. Cancer Inst.？1978, 61 (6), 1439–1449. 102856
[45]
Lamartiniere, C.A. Protection against breast cancer with genistein: A component of soy. Am. J. Clin. Nutr.？2000, 71 (6), 1705S–1707S; discussion 1708S-1709S. 10837323
[46]
Grubbs, C.J.; Farnell, D.R.; Hill, D.L.; McDonough, K.C. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J. Natl. Cancer Inst.？1985, 74 (4), 927–931. 3857386
[47]
Moller, F.J.; Diel, P.; Zierau, O.; Hertrampf, T.; Maass, J.; Vollmer, G. Long-term dietary isoflavone exposure enhances estrogen sensitivity of rat uterine responsiveness mediated through estrogen receptor alpha. Toxicol. Lett.？2010, 196, 142–153, doi:10.1016/j.toxlet.2010.03.1117. 20381596
[48]
Varayoud, J.; Ramos, J.G.; Bosquiazzo, V.L.; Munoz-de-Toro, M.; Luque, E.H. Developmental exposure to Bisphenol a impairs the uterine response to ovarian steroids in the adult. Endocrinology？2008, 149 (11), 5848–5860, doi:10.1210/en.2008-0651. 18653720
[49]
Freni-Titulaer, L.W.; Cordero, J.F.; Haddock, L.; Lebron, G.; Martinez, R.; Mills, J.L. Premature thelarche in Puerto Rico. A search for environmental factors. Am. J. Dis. Child.？1986, 140 (12), 1263–1267. 3776944
[50]
Iguchi, T.; Fukazawa, Y.; Uesugi, Y.; Takasugi, N. Polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol in vivo and in vitro. Biol. Reprod.？1990, 43 (3), 478–484, doi:10.1095/biolreprod43.3.478. 2271729
Badger, T.M.; Gilchrist, J.M.; Pivik, R.T.; Andres, A.; Shankar, K.; Chen, J.R.; Ronis, M.J. The health implications of soy infant formula. Am. J. Clin. Nutr.？2009, 89 (5), 1668–1672, doi:10.3945/ajcn.2009.26736U. 19357221
[53]
Preeyasombat, C.; Kenny, F.M. Urocytograms in normal children and various abnormal conditions. Pediatrics？1966, 38 (3), 436–443. 5918392
[54]
Stoker, T.E.; Parks, L.G.; Gray, L.E.; Cooper, R.L. Endocrine-disrupting chemicals: Prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee. Crit. Rev. Toxicol.？2000, 30 (2), 197–252. 10759431
[55]
Frisch, R.E.; Revelle, R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science？1970, 169 (943), 397–399. 5450378
[56]
Frisch, R.E.; Hegsted, D.M.; Yoshinaga, K. Body weight and food intake at early estrus of rats on a high-fat diet. Proc. Natl. Acad. Sci. USA？1975, 72 (10), 4172–4176, doi:10.1073/pnas.72.10.4172.
[57]
Ojeda, S.R.; Urbanski, H.F. Puberty in the Rat, 2nd ed.; Raven Press: New York, NY, USA, 1994.
[58]
Newbold, R.R.; Padilla-Banks, E.; Jefferson, W.N. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology？2006, 147 (6), S11–S17, doi:10.1210/en.2005-1164. 16690809
[59]
Titus-Ernstoff, L.; Troisi, R.; Hatch, E.E.; Wise, L.A.; Palmer, J.; Hyer, M.; Kaufman, R.; Adam, E.; Strohsnitter, W.; Noller, K.; Herbst, A.L.; Gibson-Chambers, J.; Hartge, P.; Hoover, R.N. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int. J. Epidemiol.？2006, 35 (4), 862–868. 16723367
